Titan Medical (NASDAQ:TMDI)
Gráfico Histórico do Ativo
1 Ano : De Abr 2019 até Abr 2020
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq:
TMDI), a medical device company focused on the design, development
and commercialization of a robotic surgical system for application in
single-port minimally invasive surgery (“MIS”), today announced that
David McNally, President and CEO of the Company, will present a
corporate overview at the Bloom Burton & Co. Healthcare Investor
Conference on Tuesday, April 30 at 1:30 p.m. Eastern time. The
conference will be held April 30-May 1 at the Metro Toronto Convention
Centre, in Toronto, Canada.
Mr. McNally’s presentation will be webcast live and available for replay
in the Investors section of Titan Medical’s website at titanmedicalinc.com/investors.
About Titan MedicalTitan Medical Inc. is focused on
computer-assisted robotic surgical technologies for application in MIS.
The Company is developing the SPORT Surgical System, a single-port
robotic surgical system comprised of a surgeon-controlled patient cart
that includes a 3D high-definition vision system and multi-articulating
instruments for performing MIS procedures, and a surgeon workstation
that provides an advanced ergonomic interface to the patient cart and a
3D endoscopic view inside the patient’s body. Titan intends initially to
pursue focused surgical indications for the SPORT Surgical System, which
may include one or more of gynecologic, urologic, colorectal or general
For more information, please visit the Company’s website at www.titanmedicalinc.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190423005179/en/
LHA Investor RelationsKim Sutton Golodetz(212) email@example.comBruce